B2 THYMOMA

Clinical trials for B2 THYMOMA explained in plain language.

Never miss a new study

Get alerted when new B2 THYMOMA trials appear

Sign up with your email to follow new studies for B2 THYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Engineered immune cells take on rare thymus cancers

Disease control Recruiting now

This early-stage study tests a new treatment using specially engineered immune cells (CAR-NK cells) to attack cancer cells in adults with thymoma or thymic carcinoma that has come back or not responded to standard therapy. About 36 participants will receive one of three types of …

Matched conditions: B2 THYMOMA

Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control

Last updated May 26, 2026 12:09 UTC

B2 THYMOMA

Get alerted when new B2 THYMOMA trials appear

Engineered immune cells take on rare thymus cancers